Provider

Christopher McGhee says that, along with the acquisition, Current Health will have a "return to scrappiness and that startup spirit."

The company offers an AI-enabled workflow automation platform for administrative tasks pertaining to specialty medications. 

The company will use the funds to hasten product development, engineering and go-to-market efforts to meet market demand.  

Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.

Connor Glass, founder and CEO of Phantom Neuro, explains how the company's muscle-machine interface for amputees is enabling the development of advanced prosthetic limbs designed to function as natural extensions of the human body.

Essex County College's Elvy Vieira says the college is increasing access to health technology jobs by offering a data science degree and credentialing courses, as well as a dual enrollment program for high schoolers.

The company will use the funds to invest in research and development and to scale its voice AI platform.   

Employees will have access to clinical content and more than 900 U.S. clinics that specialize in fertility, urology and menopause.  

The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.

The Series E funding comes four months after the company secured $250 million in a Series D round.